SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Arce-Salinas, C.A.
Right arrow Articles by Alarcón-Segovia, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arce-Salinas, C.A.
Right arrow Articles by Alarcón-Segovia, D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Factors associated with chronic renal failure in 121 patients with diffuse proliferative lupus nephritis: a case-control study

C.A. Arce-Salinas

Departments of Immunology and Rheumatology, Instituto Nacional de la Nutrici6n Salvador Zubiran, Vasco de Quiroga 15, Tlalpan 14000, México DF, Mexico

A.R. Villa

Departments of Immunology and Rheumatology, Instituto Nacional de la Nutrici6n Salvador Zubiran, Vasco de Quiroga 15, Tlalpan 14000, México DF, Mexico

J.O. Martínez-Rueda

Departments of Immunology and Rheumatology, Instituto Nacional de la Nutrici6n Salvador Zubiran, Vasco de Quiroga 15, Tlalpan 14000, México DF, Mexico

L. Muñoz

Departments of Pathology, Instituto Nacional de la Nutrici6n Salvador Zubiran, Vasco de Quiroga 15, Tlalpan 14000, México DF, Mexico

M.H. Cardiel

Departments of Immunology and Rheumatology, Instituto Nacional de la Nutrici6n Salvador Zubiran, Vasco de Quiroga 15, Tlalpan 14000, México DF, Mexico

J. Alcocer-Varela

Departments of Immunology and Rheumatology, Instituto Nacional de la Nutrici6n Salvador Zubiran, Vasco de Quiroga 15, Tlalpan 14000, México DF, Mexico

D. Alarcón-Segovia

Departments of Immunology and Rheumatology, Instituto Nacional de la Nutrici6n Salvador Zubiran, Vasco de Quiroga 15, Tlalpan 14000, México DF, Mexico

Lupus nephritis remains an important problem in patients with systemic lupus erythematosus (SLE). Some patients with diffuse proliferative lupus nephritis (DPLN) develop chronic renal failure (CRF). A case-control study was designed to determine the variables associated with CRF in patients with DPLN. We studied 121 patients with biopsy-proven DPLN seen in our institution from 1970 to 1988. There were 34 patients who developed CRF, the remaining were their controls. Clinical charts were reviewed and a pathologist re-scored blindly both activity and chronicity indices. The mean of age at SLE onset was 24.1 ± 7.9 years; the mean disease duration was 9.2 ± 6.1 years for controls and 6.1 ± 5 years for patients. The main variables associated with CRF were male sex, HR (hazard ratio): 12.6 (95% CI 1.6-98.2); activity index, HR 2.59 (1.07-6.3) ; severe infections, HR 2.9 (1.2-7.3); number of antihypertensive drugs, HR 2.5 (1.4-4.7); cellular crescents, HR 1.6 (1.2-2); and interstitial inflammation, HR 2.7 (1.5-5.1). A protective effect was observed with longer use of ≤20 mg of prednisone, HR 0.53 (95% CI 0.34-0.8); azathioprine, HR 0.6 (0.4-0.8); and length of formal education, HR 0.3 (0.09-0.94). Our results indicate that maleness, activity index, extracapillary proliferation and interstitial inflammation, as well as hypertension and severe infections associate with CRF in patients with DPLN, and treatment and higher education, perhaps through better therapeutic compliance, may be protective.

Key Words: nephritis • prognostic factors • diffuse proliferative glomerulonephritis

Lupus, Vol. 4, No. 3, 197-203 (1995)
DOI: 10.1177/096120339500400306


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
LupusHome page
W.P. de Castro, J.V. Morales, M.B. Wagner, M. Graudenz, M.I. Edelweiss, and L.F. Goncalves
Hypertension and Afro-descendant ethnicity: a bad interaction for lupus nephritis treated with cyclophosphamide?
Lupus, September 1, 2007; 16(9): 724 - 730.
[Abstract] [PDF]


Home page
LupusHome page
J Cortes-Herandez, J Ordi-Ros, M Labrador, A Segarra, J L Tovar, E Balada, and M Vilardell-Tarres
Predictors of poor renal outcome in patients with lupus nephritis treated with combined pulses of cyclophosphamide and methylprednisolone
Lupus, April 1, 2003; 12(4): 287 - 296.
[Abstract] [PDF]


Home page
Nephrol Dial TransplantHome page
C. W. Yoo, M.-K. Kim, and H. S. Lee
Predictors of renal outcome in diffuse proliferative lupus nephropathy: data from repeat renal biopsy
Nephrol. Dial. Transplant., October 1, 2000; 15(10): 1604 - 1608.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
B Rzany, J Coresh, P K Whelton, and M Petri
Risk factors for hypercreatinemia in patients with systemic lupus erythematosus
Lupus, September 1, 1999; 8(7): 532 - 540.
[Abstract] [PDF]


Home page
Nephrol Dial TransplantHome page
J. Heaf, H. Lokkegaard, and S. Larsen
The epidemiology and prognosis of glomerulonephritis in Denmark 1985–1997
Nephrol. Dial. Transplant., August 1, 1999; 14(8): 1889 - 1897.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
M. Mosca, A. Pasquariello, A. Tavoni, L. Moriconi, I. Moneta, M. Innocenti, W. Bencivelli, and S. Bombardieri
Predictors of renal outcome in diffuse proliferative glomerulonephritis in systemic lupus erythematosus
Lupus, January 1, 1997; 6(4): 371 - 378.
[Abstract] [PDF]



Advertisement